Gainers
- Theriva Biologics TOVX shares moved upwards by 34.2% to $6.31 during Monday's pre-market session. The market value of their outstanding shares is at $6.3 million.
- Emergent BioSolutions EBS shares rose 17.62% to $10.48. The market value of their outstanding shares is at $549.1 million.
- LogicMark LGMK stock moved upwards by 14.96% to $0.19. The market value of their outstanding shares is at $2.2 million.
- Synaptogenix SNPX stock increased by 14.95% to $4.06. The market value of their outstanding shares is at $5.3 million.
- Milestone Scientific MLSS shares moved upwards by 11.9% to $1.08. The market value of their outstanding shares is at $83.4 million.
- Biomea Fusion BMEA shares moved upwards by 11.41% to $8.49. The company's market cap stands at $307.4 million.
Losers
- NuCana NCNA shares declined by 48.3% to $4.0 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million.
- Catheter Precision VTAK shares declined by 27.95% to $0.98.
- Ekso Bionics Holdings EKSO stock declined by 15.18% to $0.95. The company's market cap stands at $17.5 million.
- Nutex Health NUTX shares decreased by 7.69% to $20.18. The market value of their outstanding shares is at $102.2 million.
- Alnylam Pharmaceuticals ALNY shares fell 7.5% to $265.51. The market value of their outstanding shares is at $34.0 billion.
- Exicure XCUR shares declined by 6.42% to $1.75. The market value of their outstanding shares is at $3.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BMEABiomea Fusion Inc
$4.223.43%
EBSEmergent BioSolutions Inc
$8.070.12%
EKSOEkso Bionics Holdings Inc
$0.5936-8.11%
LGMKLogicMark Inc
$1.52-2.56%
MLSSMilestone Scientific Inc
$0.925016.1%
NCNANuCana PLC
$1.21-%
NUTXNutex Health Inc
$29.38-0.07%
SNPXSynaptogenix Inc
$3.0720.9%
TOVXTheriva Biologics Inc
$1.215.22%
VTAKCatheter Precision Inc
$0.33402.14%
XCURExicure Inc
$16.907.37%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in